Nuwellis Will Showcase Aquadex System at Four October Events
The medical technology firm will target clinical markets in pediatrics, critical care, and heart failure throughout October 2026.
Updated on Oct. 1, 2026 in Healthcare
Live Poll
Do you trust that new medical technology investments improve care for patients with chronic conditions?
Nuwellis will promote its Aquadex SmartFlow system for ultrafiltration therapy at four specialized medical conferences across the United States in October 2026. These appearances aim to expand the company's commercial reach into critical growth segments.
Why it matters
The company is focusing its commercial strategy on pediatrics, heart failure, and nephrology to drive awareness of its ultrafiltration technology. Engaging directly with clinicians at these specialized summits is a critical tactic for increasing product adoption in complex care environments.
Nuwellis will staff booths at four medical conferences, targeting an audience that includes 12,000 kidney professionals at ASN Kidney Week. The Aquadex SmartFlow system is currently indicated for physician-prescribed fluid removal in patients weighing 20 kilograms or more.
The players
Nuwellis
A medical technology company that develops and markets ultrafiltration systems for fluid management.
The details
Nuwellis is deploying a direct-engagement strategy, utilizing physical booths at conferences in Houston, Baltimore, Phoenix, and Denver to connect with clinicians. By showcasing the Aquadex SmartFlow system, the company intends to educate specialists on controlled fluid removal therapy for pediatric and critical care applications. This operational push centers on securing physician awareness within specialized heart failure and nephrology markets.
Timeline
October 6-8, 2026: Pediatric Paracorporeal and Extracorporeal Therapies Summit in Houston.
October 9-10, 2026: Society of Thoracic Surgeons Perioperative & Critical Care Conference in Baltimore.
October 9-12, 2026: Heart Failure Society of America Annual Scientific Meeting in Phoenix.
October 21-25, 2026: American Society of Nephrology Kidney Week in Denver.
Market Landscape
Nuwellis's strategy follows the broader industry trend of prioritizing specialized clinical summits to capture market share in complex care segments. This approach mirrors standard commercialization patterns for medical device firms attempting to penetrate the heart failure and critical care sectors.
Operators in the medical technology and clinical care space should watch these conferences as a bellwether for the adoption of ultrafiltration therapy. Keep note of the clinical feedback and physician adoption patterns emerging from these segments to refine your own product positioning.
The takeaway
Commercial growth for medical device firms relies heavily on targeted outreach at specialized clinical gatherings where physician decision-makers aggregate. Monitor the feedback from these October 2026 summits to identify emerging trends in critical care and nephrology treatment protocols.
Further reading
For more on the medical device market, visit the Healthcare section.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust that new medical technology investments improve care for patients with chronic conditions?
